About Marshfield Clinic-Minocqua Center
"Marshfield Medical Center-Minocqua (medical offices) has been a member of the Marshfield Clinic system since 1989. More than 70 physicians provide care in a variety of specialties including anesthesiology, cardiology, emergency medicine, family medicine, general and vascular surgery, internal medicine, nephrology, neurology, neuropsychology, nutrition services,obstetrics and gynecology, occupational health, oncology and hematology, ophthalmology, orthopedic surgery, orthotics and prosthetics, otolaryngology, pain management, pediatrics,physical therapy, plastic surgery, podiatry, psychiatry, radiation oncology, radiology, sleep medicine, urgent care, and urology."
Clinical Trials at Marshfield Clinic-Minocqua Center
During the past decade, Marshfield Clinic-Minocqua Center conducted 184 clinical trials. In the 10-year time frame, 184 clinical trials started and 142 clinical trials were completed, i.e. on
average, 77.2% percent of trials that started reached the finish line to date. In the past 5 years, 78 clinical trials started and 73 clinical trials were completed. i.e. 93.6%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Marshfield Clinic-Minocqua Center" #1 sponsor was "National Cancer Institute (NCI)" with 137 trials, followed by "Alliance for Clinical Trials in Oncology" with 58 trials
sponsored, "SWOG Cancer Research Network" with 47 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 28 trials sponsored and "NRG Oncology"
with 28 trials sponsored. Other sponsors include 41 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Marshfield Clinic-Minocqua Center"
#1 collaborator was "National Cancer Institute (NCI)" with 186 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator and "NCIC Clinical Trials Group" with 8 trials as a collaborator. Other collaborators include 61 different institutions and companies that were
collaborators in the rest 49 trials.
Clinical Trials Conditions at Marshfield Clinic-Minocqua Center
According to Clinical.Site data, the most researched conditions in "Marshfield Clinic-Minocqua Center" are
"Breast Cancer" (17 trials), "Colorectal Cancer" (10 trials), "Lymphoma" (10 trials), "Recurrent Ovarian Carcinoma" (9 trials) and "Recurrent Squamous Cell Lung Carcinoma" (9 trials). Many other conditions were trialed in "Marshfield Clinic-Minocqua Center" in a lesser frequency.
Clinical Trials Intervention Types at Marshfield Clinic-Minocqua Center
Most popular intervention types in "Marshfield Clinic-Minocqua Center" are "Drug" (254 trials), "Other" (196 trials), "Biological" (130 trials), "Procedure" (87 trials) and "Radiation" (54 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (87 trials), "Quality-of-Life Assessment" (79 trials), "Questionnaire Administration" (43 trials), "Computed Tomography" (40 trials) and "Biospecimen Collection" (37 trials). Other intervention names were less common.
Clinical Trials Genders at Marshfield Clinic-Minocqua Center
The vast majority of trials in "Marshfield Clinic-Minocqua Center" are
262 trials for "All" genders, 54 trials for "Female" genders and 14 trials for "Male" genders.
Clinical Trials Status at Marshfield Clinic-Minocqua Center
Currently, there are NaN active trials in "Marshfield Clinic-Minocqua Center".
undefined are not yet recruiting,
82 are recruiting,
123 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 97 completed trials in Marshfield Clinic-Minocqua Center,
7 suspended trials,
and 16 terminated clinical trials to date.
Out of the total trials that were conducted in Marshfield Clinic-Minocqua Center, 9 "Phase 1"
clinical trials were conducted, 140 "Phase 2" clinical
trials and 175 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 10 trials that are defined as “Not Applicable".